Clinical Outcomes of Low-Grade Cytomegalovirus DNAemia in Hematopoietic Stem Cell Transplantation Recipients Receiving Letermovir Prophylaxis. (PubMed, J Med Virol) - Dec 4, 2025 - "No significant associations were observed with engraftment failure (p = 0.098), disease relapse (p = 0.165), or all-cause mortality (p = 0.537). Our findings suggest that close monitoring may be sufficient for low-grade DNAemia under letermovir prophylaxis."
Clinical data • Journal • Retrospective data • Bone Marrow Transplantation • Cytomegalovirus Infection • Hematological Disorders • Infectious Disease • Transplantation
|
|
Chan Mi Lee; Chang Kyung Kang; Dong-Yeop Shin; Eun-Jeong Jeong; Hyeon Jae Jo; Inho Kim; Ja Min Byun; Jung Soo Son; Junshik Hong; Nam Joong Kim; Pyeong Gyun Choe; Sung-Soo Yoon; Wan Beom Park; Youngil Koh
|